StemWave provides a non-invasive focused wave medical device utilizing Cellular Response Technology (CRT+) to support natural recovery in patients. The company supports adoption with tailored clinical training, business guidance, and marketing blueprints for medical practices. This technology allows clinics to treat a wider variety of musculoskeletal and soft tissue cases efficiently, increasing patient volume and collections.
Funding
Funding not disclosed
Founders
Product
Problem
Many patients experience chronic and acute pain in the neck, back, and extremities, requiring effective and non-invasive treatment options. Existing treatments may not provide sufficient relief or may involve invasive procedures and long recovery times.
Solution
StemWave offers a non-invasive focused wave device that utilizes Cellular Response Technology (CRT+) to facilitate natural recovery. The device delivers targeted acoustic waves to stimulate cellular repair and reduce pain in affected areas. Treatments are quick, typically lasting 10 minutes or less, allowing clinics to increase patient volume. StemWave provides a versatile solution for treating a wide range of conditions, including those affecting the neck, back, upper and lower extremities, and soft tissues.
Target Audience
The primary customers are medical professionals, including doctors and clinic owners, seeking to improve patient outcomes and expand their service offerings with a non-invasive pain management solution.
Features
- Non-invasive focused wave technology for targeted pain relief
- Cellular Response Technology (CRT+) to stimulate natural healing processes
- Short treatment times (10 minutes or less) for increased patient throughput
- Versatile applications for neck, back, upper/lower extremities, and soft tissue injuries
- Comprehensive clinical training program with proven treatment protocols
- Marketing blueprint to help clinics generate new patients